|
1
|
Jiang RW, Lau KM, Hon PM, Mak TC, Woo KS
and Fung KP: Chemistry and biological activities of caffeic acid
derivatives from Salvia miltiorrhiza. Curr Med Chem. 12:237–246.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhou L, Zuo Z and Chow MS: Danshen: an
overview of its chemistry, pharmacology, pharmacokinetics and
clinical use. J Clin Pharmacol. 45:1345–1359. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Zhang H, Yu C, Jia JY, Leung SW, Siow YL,
Man RY and Zhu DY: Contents of four active components in different
commercial crude drugs and preparations of danshen (Salvia
miltiorrhiza). Acta Pharmacol Sin. 23:1163–1168. 2002.PubMed/NCBI
|
|
4
|
Wang AM, Sha SH, Lesniak W and Schacht J:
Tanshinone (Salviae miltiorrhizae extract) preparations attenuate
aminogly-coside-induced free radical formation in vitro and
ototoxicity in vivo. Antimicrob Agents Chemother. 47:1836–1841.
2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Fu J, Huang H, Liu J, Pi R, Chen J and Liu
P: Tanshinone IIA protects cardiac myocytes against oxidative
stress-triggered damage and apoptosis. Eur J Pharmacol.
568:213–221. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ling S, Nheu L, Dai A, Guo Z and
Komesaroff P: Effects of four medicinal herbs on human vascular
endothelial cells in culture. Int J Cardiol. 128:350–358. 2008.
View Article : Google Scholar
|
|
7
|
Asahara T, Murohara T, Sullivan A, et al:
Isolation of putative progenitor endothelial cells for
angiogenesis. Science. 275:964–967. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Humbert M, Sitbon O and Simonneau G:
Treatment of pulmonary arterial hypertension. N Engl J Med.
351:1425–1436. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Yang JX, Pan YY, Zhao YY and Wang XX:
Endothelial progenitor cell-based therapy for pulmonary arterial
hypertension. Cell Transplant. 22:1325–1336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Li YJ, Duan CL, Liu JX and Xu YG:
Pro-angiogenic actions of Salvianolic acids on in vitro cultured
endothelial progenitor cells and chick embryo chorioallantoic
membrane model. J Ethnopharmacol. 131:562–566. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zhang Y, Yang X, Bian F, et al: TNF-α
promotes early atherosclerosis by increasing transcytosis of LDL
across endothelial cells: crosstalk between NF-κB and PPAR-γ. J
Mol. Cell Cardiol. 72:85–94. 2014. View Article : Google Scholar
|
|
12
|
Chen TG, Zhong ZY, Sun GF, Zhou YX and
Zhao Y: Effects of tumour necrosis factor-alpha on activity and
nitric oxide synthase of endothelial progenitor cells from
peripheral blood. Cell Prolif. 44:352–359. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yang JX, Tang WL and Wang XX:
Superparamagnetic iron oxide nanoparticles may affect endothelial
progenitor cell migration ability and adhesion capacity.
Cytotherapy. 12:251–259. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Yang JX, Chen B, Pan YY, Han J, Chen F and
Hu SJ: Zoledronate attenuates angiogenic effects of angiotensin
II-stimulated endothelial progenitor cells via RhoA and MAPK
signaling. PLoS One. 7:e465112012. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ding M, Ye TX, Zhao GR, Yuan YJ and Guo
ZX: Aqueous extract of Salvia miltiorrhiza attenuates increased
endothelial permeability induced by tumor necrosis factor-alpha.
Int Immunopharmacol. 5:1641–1651. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ross R: Atherosclerosis - an inflammatory
disease. N Engl J Med. 340:115–126. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang GD, Zhang H, Lin R, Wang WR, Shi XL,
Liu Y and Ji QL: Down-regulation of CD40 gene expression and
inhibition of apoptosis with Danshensu in endothelial cells. Basic
Clin Pharmacol Toxicol. 104:87–92. 2009. View Article : Google Scholar
|
|
18
|
Lerman A, Edwards BS, Hallett JW, Heublein
DM, Sandberg SM and Burnett JC Jr: Circulating and tissue
endothelin immuno-reactivity in advanced atherosclerosis. N Engl J
Med. 325:997–1001. 1991. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hill JM, Zalos G, Halcox JP, Schenke WH,
Waclawiw MA, Quyyumi AA and Finkel T: Circulating endothelial
progenitor cells, vascular function and cardiovascular risk. N Engl
J Med. 348:593–600. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Asahara T, Takahashi T, Masuda H, et al:
VEGF contributes to postnatal neovascularization by mobilizing bone
marrow-derived endothelial progenitor cells. EMBO J. 18:3964–3972.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Griese DP, Ehsan A, Melo LG, et al:
Isolation and transplantation of autologous circulating endothelial
cells into denuded vessels and prosthetic grafts: implications for
cell-based vascular therapy. Circulation. 108:2710–2715. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Werner N, Junk S, Laufs U, Link A, Walenta
K, Bohm M and Nickenig G: Intravenous transfusion of endothelial
progenitor cells reduces neointima formation after vascular injury.
Circ Res. 93:e17–24. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ji KT, Chai JD, Xing C, Nan JL, Yang PL
and Tang JF: Danshen protects endothelial progenitor cells from
oxidized low-density lipoprotein induced impairment. J Zhejiang
Univ Sci B. 11:618–626. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Fan GW, Gao XM, Wang H, et al: The
anti-inflammatory activities of Tanshinone IIA, an active component
of TCM, are mediated by estrogen receptor activation and inhibition
of iNOS. J Steroid Biochem Mol Biol. 113:275–280. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chang CC, Chu CF, Wang CN, Wu HT, Bi KW,
Pang JH and Huang ST: The anti-atherosclerotic effect of tanshinone
IIA is associated with the inhibition of TNF-alpha-induced VCAM-1,
ICAM-1 and CX3CL1 expression. Phytomedicine. 21:207–216. 2014.
View Article : Google Scholar
|
|
26
|
Jiang KY, Ruan CG, Gu ZL, Zhou WY and Guo
CY: Effects of tanshinone II-A sulfonate on adhesion molecule
expression of endothelial cells and platelets in vitro. Acta
Pharmacol Sin. 19:47–50. 1998.
|
|
27
|
Niu XL, Ichimori K, Yang X, Hirota Y,
Hoshiai K, Li M and Nakazawa H: Tanshinone II-A inhibits low
density lipoprotein oxidation in vitro. Free Radic Res. 33:305–312.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Libby P, Ridker PM and Maseri A:
Inflammation and atherosclerosis. Circulation. 105:1135–1143. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Shindo A, Tanemura H, Yata K, Hamada K,
Shibata M, Umeda Y, Asakura F, Toma N, Sakaida H, Fujisawa T, et
al: Inflammatory biomarkers in atherosclerosis: Pentraxin 3 can
become a novel marker of plaque vulnerability. PLoS One.
9:e1000452014. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Inoue S, Egashira K, Ni W, et al:
Anti-monocyte chemoattractant protein-1 gene therapy limits
progression and destabilization of established atherosclerosis in
apolipoprotein E-knockout mice. Circulation. 106:2700–2706. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Charo IF and Taubman MB: Chemokines in the
pathogenesis of vascular disease. Circ Res. 95:858–866. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Epstein SE, Stabile E, Kinnaird T, Lee CW,
Clavijo L and Burnett MS: Janus phenomenon: the interrelated
tradeoffs inherent in therapies designed to enhance collateral
formation and those designed to inhibit atherogenesis. Circulation.
109:2826–2831. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
McPherson R and Davies RW: Inflammation
and coronary artery disease: insights from genetic studies. Can J
Cardiol. 28:662–666. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Lin R, Wang WR, Liu JT, Yang GD and Han
CJ: Protective effect of tanshinone IIA on human umbilical vein
endo-thelial cell injured by hydrogen peroxide and its mechanism. J
Ethnopharmacol. 108:217–222. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Fang ZY, Lin R, Yuan BX, Yang GD, Liu Y
and Zhang H: Tanshinone IIA downregulates the CD40 expression and
decreases MMP-2 activity on atherosclerosis induced by high fatty
diet in rabbit. J Ethnopharmacol. 115:217–222. 2008. View Article : Google Scholar
|
